EUVIMEDEUVIMED entdecken
Crossref

L26/P-762 Does Rescue Subcutaneous Progesterone Equalize Outcomes in HRT-FET Cycles with Low Serum Progesterone on the Day of Transfer?

B. Berker, N.B. Kaplan, B. Aslan

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.1089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von B. Berker und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Is routine progesterone monitoring necessary on the day of FET in HRT cycles, and does rescue subcutaneous progesterone effectively compensate for low serum levels? Summary answer In HRT-FET cycles, transfer-day progesterone monitoring identifies insufficient levels, yet rescue subcutaneous progesterone fails to equalize clinical pregnancy rates compared to optimal serum levels. What is known already In hormone replacement therapy (HRT) cycles, there is no corpus luteum, making exogenous progesterone the sole source for endometrial preparation. Low serum P4 on the day of FET is linked to poor outcomes. While individualized luteal phase support (iLPS) with rescue protocols is gaining popularity, its ability to “save” a cycle with low P4 remains controversial. Study design, size, duration This retrospective cohort study analyzed 180 HRT-FET cycles conducted between 2024 and 2025. Patients were categorized into two groups: those with progesterone monitoring on the day of embryo transfer (n = 123) and those without monitoring (n = 57). In the monitored group, a rescue protocol of 50 mg subcutaneous progesterone was initiated if serum levels were <10 ng/mL. Demographic data and embryo quality were homogenous across groups except for the day of embryo transfer. Participants/materials, setting, methods There were no statistically significant differences between groups regarding age, BMI, duration of infertility, or basal ovarian reserve markers. Embryo Quality High-quality blastocyst transfer (Day 5) was prioritized in both groups. Protocol All patients used vaginal micronized P4 (800 mg). In the monitored group, those with P4 <10 ng/mL received rescue subcutaneous P4 (50 mg/day). Main results and the role of chance Progesterone monitoring identified that 40.7% (50/123) of patients in the HRT group failed to reach the target threshold of 10 ng/mL. Demographic analysis showed no significant differences between the monitored and non-monitored groups regarding age (p = 0.175), infertility duration (p = 0.165), or smoking status (p = 1.00). Despite the non-monitored group having a significantly higher rate of Day 5 embryo transfers (77.2% vs. 52.8%, p = 0.002), clinical pregnancy rates (CPR) were comparable between the total monitored (26.0%) and non-monitored (33.3%, p = 0.316) populations. The most critical finding emerged within the monitored group: patients with optimal P4 levels (>10 ng/mL) achieved a CPR of 33.8% (25/73). In contrast, patients with low P4 (<10 ng/mL) who received 50 mg subcutaneous rescue progesterone had a significantly lower CPR of 14.3% (7/49, p = 0.021). Live birth rates followed a similar trend (23% vs. 10.2%, p = 0.093). These results indicate that while monitoring is vital, the current rescue protocol fails to equalize outcomes with the optimal P4 group, and the observed differences are statistically significant (p < 0.05), suggesting they are unlikely due to chance. Limitations, reasons for caution The retrospective design and limited sample size reduce statistical power. A significant disparity in Day 5 embryo transfers—77.2% in the non-monitored group versus 52.8% in the monitored group (p = 0.002)—may have influenced baseline pregnancy rates. Results should be interpreted with caution due to this potential confounding factor despite homogenous basic demographics.. Wider implications of the findings Routine progesterone monitoring is essential for identifying patients with suboptimal absorption in HRT cycles. However, the lower success rates in the rescue group suggest that 50 mg subcutaneous progesterone may be insufficient or initiated too late. These findings underscore the need for earlier intervention or more potent individualized support strategies. Trial registration number No

Zitieren

APA

Berker, B., Kaplan, N., & Aslan, B. (2026). L26/P-762 Does Rescue Subcutaneous Progesterone Equalize Outcomes in HRT-FET Cycles with Low Serum Progesterone on the Day of Transfer?. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1089

Vancouver

Berker B, Kaplan N, Aslan B. L26/P-762 Does Rescue Subcutaneous Progesterone Equalize Outcomes in HRT-FET Cycles with Low Serum Progesterone on the Day of Transfer?. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1089

BibTeX
@article{Berker2026,
  author = {Berker, B. and Kaplan, N.B. and Aslan, B.},
  title = {L26/P-762 Does Rescue Subcutaneous Progesterone Equalize Outcomes in HRT-FET Cycles with Low Serum Progesterone on the Day of Transfer?},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.1089}
}
Kostenlos starten →